Sunday, January 17, 2010

Robinul Forte


See also: Generic Robinul


Robinul Forte is a brand name of glycopyrrolate, approved by the FDA in the following formulation(s):


ROBINUL FORTE (glycopyrrolate - tablet; oral)



  • Manufacturer: SHIONOGI INC

    Approved Prior to Jan 1, 1982

    Strength(s): 2MG [RLD][AA]

Has a generic version of Robinul Forte been approved?


A generic version of Robinul Forte has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Robinul Forte and have been approved by the FDA:


glycopyrrolate tablet; oral



  • Manufacturer: BOCA PHARMA

    Approval date: October 19, 2011

    Strength(s): 2MG [AA]


  • Manufacturer: COREPHARMA

    Approval date: December 22, 2004

    Strength(s): 2MG [AA]


  • Manufacturer: DR REDDYS LABS LTD

    Approval date: March 21, 2008

    Strength(s): 2MG [AA]


  • Manufacturer: PAR PHARM

    Approval date: August 31, 2006

    Strength(s): 2MG [AA]


  • Manufacturer: RANBAXY

    Approval date: August 18, 2009

    Strength(s): 2MG [AA]


  • Manufacturer: VINTAGE

    Approval date: December 29, 2008

    Strength(s): 2MG [AA]


  • Manufacturer: WEST WARD

    Approval date: March 5, 2009

    Strength(s): 2MG [AA]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Robinul Forte. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Method for increasing the bioavailability of glycopyrrolate
    Patent 7,091,236
    Issued: August 15, 2006
    Inventor(s): Roberts; Alan & Venkataraman; Bala
    Assignee(s): Sciele Pharma, Inc.
    The invention relates to a method of increasing the bioavailability of glycopyrrolate by administration of a therapeutically effective amount of glycopyrrolate without food.
    Patent expiration dates:

    • April 24, 2024
      ✓ 
      Patent use: FOR USE AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PEPTIC ULCER



See also...

  • Robinul Forte Consumer Information (Wolters Kluwer)
  • Robinul Forte Consumer Information (Cerner Multum)
  • Robinul Forte Advanced Consumer Information (Micromedex)
  • Glycopyrrolate Consumer Information (Wolters Kluwer)
  • Glycopyrrolate Solution Consumer Information (Wolters Kluwer)
  • Glycopyrrolate Tablets Consumer Information (Wolters Kluwer)
  • Glycopyrrolate Consumer Information (Cerner Multum)
  • Glycopyrrolate Advanced Consumer Information (Micromedex)
  • Glycopyrrolate AHFS DI Monographs (ASHP)

No comments:

Post a Comment